Status:
TERMINATED
Right Ventricular (RV) Pacing in Early Post-operative Continuous Flow Left Ventricular Assist Device (LVAD)
Lead Sponsor:
Duke University
Collaborating Sponsors:
Medtronic
Conditions:
Heart Failure
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Continuous right ventricular (RV) pacing demonstrates harm in patients with normal left ventricular (LV) function as well as in patients with cardiomyopathy and clinical heart failure. However, little...
Eligibility Criteria
Inclusion
- Age ≥ 18 years old, both men and women
- Existing implantable cardioverter-defibrillator (ICD)
- Referred for implantation of a continuous flow LVAD
Exclusion
- Permanent left ventricular epicardial defibrillator in place
- Congenital heart disease with single ventricle physiology
- Right ventricular assist device (RVAD) in place
- Existing pacing indication
Key Trial Info
Start Date :
September 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2012
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT01446796
Start Date
September 1 2011
End Date
October 1 2012
Last Update
March 10 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke University Medical Center
Durham, North Carolina, United States, 27710